Expressive Writing for Cancer Survivors

Completed · Not applicable

Conditions studied: Cancer Survivors

In brief

The purpose of this study is to determine whether a 1-day expressive writing intervention for adult cancer survivors improves resilience scores as measured by the Connor-Davidson Resilience Scale (CD-RISC).

Key facts

Study ID

NCT04171609

Run by

Duke University

People needed

14

Starts

2019-07-19

Expected to finish

2020-05-14

Last updated by the study team

2020-08-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Have ever received a cancer diagnosis
• Have completed cancer treatment (e.g., surgery, radiation, or chemotherapy)
• Are able to speak, read, write, and understand English
• Are cognitively able to provide consent
• Are able to travel to Durham to participate in the 1-day writing intervention

You may not qualify if…

• Cancer diagnosis was skin cancer that did not require additional treatment after surgical removal

Where it is running

• Duke Integrative Medicine — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.